StockNews.com assumed coverage on shares of SenesTech (NASDAQ:SNES – Free Report) in a report published on Saturday morning. The firm issued a sell rating on the stock.
Separately, HC Wainwright increased their price target on shares of SenesTech from $3.50 to $10.00 and gave the company a “buy” rating in a report on Thursday, December 12th.
View Our Latest Stock Report on SNES
SenesTech Trading Up 0.7 %
About SenesTech
SenesTech, Inc develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.
Recommended Stories
- Five stocks we like better than SenesTech
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- Insider Trades May Not Tell You What You Think
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- The Role Economic Reports Play in a Successful Investment Strategy
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for SenesTech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SenesTech and related companies with MarketBeat.com's FREE daily email newsletter.
